Bayer, J&J win second U.S. trial over Xarelto bleeding risks

June 12 (Reuters) - A federal jury has cleared Bayer AG and Johnson & Johnson of liability in the second trial to stem from thousands of lawsuits blaming injuries on the blood thinner Xarelto, the drug companies said on Monday. (Reporting by Nate Raymond in Boston; Editing by Dan Grebler)